The Incidence of SARS-CoV-2 Reinfection in Persons With Naturally Acquired Immunity With and Without Subsequent Receipt of a Single Dose of BNT162b2 Vaccine-Reference-Cited by-同舟云学术

The Incidence of SARS-CoV-2 Reinfection in Persons With Naturally Acquired Immunity With and Without Subsequent Receipt of a Single Dose of BNT162b2 Vaccine

Published:2022-05 Issue:5 Volume:175 Page:674-681
ISSN:0003-4819
Container-title:Annals of Internal Medicine
language:en
Short-container-title:Ann Intern Med

Author:

Gazit Sivan¹^ORCID,Shlezinger Roei²,Perez Galit³,Lotan Roni³,Peretz Asaf⁴^ORCID,Ben-Tov Amir⁵^ORCID,Herzel Esma³,Alapi Hillel³^ORCID,Cohen Dani⁶,Muhsen Khitam⁶^ORCID,Chodick Gabriel⁷,Patalon Tal¹^ORCID

Affiliation:

1. Kahn Sagol Maccabi (KSM) Research & Innovation Center and Maccabitech Institute for Research and Innovation, Maccabi Healthcare Services, Tel Aviv, Israel (S.G., T.P.)

2. Kahn Sagol Maccabi (KSM) Research & Innovation Center, Maccabi Healthcare Services, Tel Aviv, Israel (R.S.)

3. Maccabitech Institute for Research and Innovation, Maccabi Healthcare Services, Tel Aviv, Israel (G.P., R.L., E.H., H.A.)

4. Kahn Sagol Maccabi (KSM) Research & Innovation Center, Maccabi Healthcare Services, Tel Aviv, and Internal Medicine COVID-19 Ward, Samson Assuta Ashdod University Hospital, Ashdod, Israel (A.P.)

5. Kahn Sagol Maccabi (KSM) Research & Innovation Center, Maccabi Healthcare Services, and Sackler Faculty of Medicine, School of Public Health, Tel Aviv University, Tel Aviv, Israel (A.B.)

6. Sackler Faculty of Medicine, School of Public Health, Tel Aviv University, Tel Aviv, Israel (D.C., K.M.)

7. Maccabitech Institute for Research and Innovation, Maccabi Healthcare Services, and Sackler Faculty of Medicine, School of Public Health, Tel Aviv University, Tel Aviv, Israel (G.C.).

Publisher

American College of Physicians

Subject

General Medicine,Internal Medicine

Reference41 articles.

1. A correlate of protection for SARS-CoV-2 vaccines is urgently needed

2. BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Mass Vaccination Setting

3. Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine

4. Impact and effectiveness of mRNA BNT162b2 vaccine against SARS-CoV-2 infections and COVID-19 cases, hospitalisations, and deaths following a nationwide vaccination campaign in Israel: an observational study using national surveillance data

5. The Effectiveness of the Two-Dose BNT162b2 Vaccine: Analysis of Real-World Data

Cited by 45 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Quantifying Disparities in COVID-19 Vaccination Rates by Rural and Urban Areas: Cross-Sectional Observational Study;JMIR Public Health and Surveillance;2024-07-19

2. mRNA vaccine boosters and impaired immune system response in immune compromised individuals: a narrative review;Clinical and Experimental Medicine;2024-01-27

3. Adjuvanted SARS-CoV-2 spike protein vaccination elicits long-lived plasma cells in nonhuman primates;Science Translational Medicine;2024-01-03

4. Multiple SARS-CoV-2 immunizations of an unvaccinated population lead to complex immunity. A T cell reactivity study of blood donors in Antananarivo;Journal of Infection and Public Health;2024-01

5. Immunogenicity and adverse events of the COVID-19 vaccines in healthy and individuals with autoimmune diseases in an Iranian population;International Journal of Immunopathology and Pharmacology;2024-01